<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> is a <z:e sem="disease" ids="C0242354" disease_type="Disease or Syndrome" abbrv="">congenital disorder</z:e> of the connective tissue with a long history of clinical and basic science breakthroughs that have forged our understanding of <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular-disease</z:e> pathogenesis </plain></SENT>
<SENT sid="1" pm="."><plain>The biomedical importance of <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> was recently underscored by the discovery that the underlying genetic lesion impairs both tissue integrity and transforming growth factor-beta regulation of cell behavior </plain></SENT>
<SENT sid="2" pm="."><plain>This discovery has led to the successful implementation of the first pharmacological intervention in a <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective-tissue disorder</z:e> otherwise incurable by either gene-based or stem cell-based therapeutic strategies </plain></SENT>
<SENT sid="3" pm="."><plain>More generally, information gathered from the study of <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> pathogenesis has the potential to improve the clinical management of common acquired <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">disorders of connective-tissue</z:e> degeneration </plain></SENT>
</text></document>